AbbVie’s Venclyxto hit with NICE rejection
admin 29th October 2018 Uncategorised 0Draft guidelines do not recommend NHS use of AbbVie’s Venclyxto for treating relapsed or refractory chronic lymphocytic leukaemia (CLL).
More: AbbVie’s Venclyxto hit with NICE rejection
Source: News